{"id":"W4389465430","doi":"10.1212/wnl.92.15_supplement.p3.2-054","title":"Long-Term Reduction in 48-Week Confirmed Disability Progression After 5 Years of Ocrelizumab Treatment in Patients With Relapsing Multiple Sclerosis (P3.2-054)","year":2019,"lang":"en","type":"article","venue":"Neurology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Ocrelizumab; Multiple sclerosis; Medicine; Term (time); Pediatrics; Oncology; Internal medicine; Immunology; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004850858,0.0001310867,0.0003121896,0.00007831837,0.00001134052,0.00000384199,0.00004043,0.0001028294,0.0000833033],"category_scores_gemma":[0.00003305,0.0001052565,0.00004477458,0.000154589,0.0001583864,0.00006723855,0.00002753828,0.0001650175,0.000007541023],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006305172,"about_ca_system_score_gemma":0.00003044995,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002871862,"about_ca_topic_score_gemma":0.0005418978,"domain_scores_codex":[0.9988741,0.000123309,0.0002691631,0.0003573744,0.0001458167,0.0002302499],"domain_scores_gemma":[0.9995179,0.00004019425,0.00008781805,0.0002742583,0.00002830978,0.00005158327],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01981473,0.001720706,0.9594169,0.00004732718,0.000006663303,0.00003181122,0.0003070791,0.00002560644,0.00120763,4.676516e-7,0.000003699063,0.01741735],"study_design_scores_gemma":[0.009348428,0.008312486,0.9818619,0.00009416482,0.00001403916,0.000006268735,0.00001343322,0.000087196,0.0001321194,0.00000271291,0.0000496781,0.00007759315],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984637,0.00006094806,0.000001124007,0.0002169337,0.0002565029,0.0009353117,0.000004713576,0.00001867424,0.00004202056],"genre_scores_gemma":[0.9996776,0.00003593925,0.0000380973,0.0001210127,0.00001305089,0.00005296356,0.00002144051,0.00002036488,0.00001951023],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02244496,"threshold_uncertainty_score":0.4292236,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01413660887034244,"score_gpt":0.2419650215227647,"score_spread":0.2278284126524223,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}